Needle, I agree it could and should have been handled differently. At this point, it's "crying over spilt milk", though.
My bet's that covid's going to get worse with all the impatient citizens and governments. Markets will follow and risk-on spending is going to be reduced. That would include retail buyers, funds and capital markets.
We'll see, I could be wrong. Been wrong before but have done something right to be sitting here typing this crap without having to worry about my next meal, car payment, mortgage payment, etc.
My point is, Kazia has money now without having to yield on any partnership terms for at least a year or so. By that time the value of Paxalisib should be more obvious AND the risk-on / market outlook should be much better.
Just my 2 cents.
- Forums
- ASX - By Stock
- KZA
- Extreme Chronic Undervalue
Extreme Chronic Undervalue, page-84
-
- There are more pages in this discussion • 145 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
NEWS
Antler Copper Project hits major permitting milestone – air quality permit advances to final review
CC9
Chariot Corporation (ASX:CC9) refines Black Mountain strategy, launching Pilot Mine to seize U.S. lithium opportunity